► Members
► Trials
► Downloadables
► Information
► Tips
► EAA Supports
Latest Eczema Trials 2022
New South Wales
- Adults With Moderate to Severe Atopic Dermatitis
- The Hillier Study
- The Skin Hospital Clinical Trial
- Endor Natural Product Clinical Trial
- Branebrutinib for Participants With Atopic Dermatitis
- Study the Efficacy of Tezepelumab in Atopic Dermatitis
- A Study to Evaluate Risankizumab in Adult and Adolescent
- Tralokinumab Monotherapy for Adolescent Subjects
- A Study of Baricitinib in Children and Adolescents
- A Study to Evaluate Upadacitinib and Topical Corticosteroids
- Long-term Safety and Efficacy of Nemolizumab
- Efficacy and Safety of Nemolizumab
- Study to Assess the Efficacy of Vixarelimab
Queensland
- Adults With Moderate to Severe Atopic Dermatitis
- The Hillier Study
- Study the Efficacy of Tezepelumab in Atopic Dermatitis
- A Study to Evaluate Risankizumab in Adult and Adolescent
- Tralokinumab Monotherapy for Adolescent Subjects
- A Study of Baricitinib in Children and Adolescents
- A Study to Evaluate Upadacitinib and Topical Corticosteroids
- Long-term Safety and Efficacy of Nemolizumab
- Efficacy and Safety of Nemolizumab
- Study to Assess the Efficacy of Vixarelimab
Australian Capital Territory
Victoria
- Adults With Moderate to Severe Atopic Dermatitis
- Sinclair Dermatology Atopic Dermatitis
- The Hillier Study
- Victoria University Atopic Dermatitis Study
- Branebrutinib for Participants With Atopic Dermatitis
- Study the Efficacy of Tezepelumab in Atopic Dermatitis
- A Study to Evaluate Risankizumab in Adult and Adolescent
- Tralokinumab Monotherapy for Adolescent Subjects
- A Study of Baricitinib in Children and Adolescents
- Long-term Safety and Efficacy of Nemolizumab
- Efficacy and Safety of Nemolizumab
- Study to Assess the Efficacy of Vixarelimab
Western Australia
- Adults With Moderate to Severe Atopic Dermatitis
- Study the Efficacy of Tezepelumab in Atopic Dermatitis
- A Study to Evaluate Risankizumab in Adult and Adolescent
- A Study to Evaluate Upadacitinib and Topical Corticosteroids
- Long-term Safety and Efficacy of Nemolizumab
- Efficacy and Safety of Nemolizumab
South Australia
Tasmania
Northern Territory
It is not the policy of the Eczema Association of Australasia Inc to recommend or endorse any product or treatment.
It is part of the role of the Association to provide information on a wide range of products and treatments to keep those involved with eczema as fully informed as possible as to all options available. For medical advice, consult your health professional.
